Navigation Links
Omeros Corporation Reports Second Quarter 2013 Financial Results
Date:8/9/2013

SEATTLE, Aug. 9, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the second quarter of 2013.

Financial ResultsTotal operating expenses for the quarter ended June 30, 2013 were $13.3 million and included non-cash expenses of $2.1 million related to rent expense and stock-based compensation. For the same period in 2012, total operating expenses were $9.8 million, which included non-cash rent and stock-based compensation expenses of $569,000.

The increase in total operating expenses for the quarter ended June 30, 2013 is primarily due to expenses related to advancing our MASP-2 program toward the clinic, the non-cash rent expense and stock-based compensation discussed above, preparing the NDA and MAA for OMS302, the planned commercial launch of OMS302 in 2014, and conducting our Phase 1 clinical program evaluating OMS824. These higher costs were partially offset by lower overall clinical trial expenses related to the completion of our OMS302 Phase 3 clinical program in January 2013 and the completion of our first OMS103HP Phase 3 clinical trial in arthroscopic partial meniscectomy patients in December 2012.

Total revenue for the quarter ended June 30, 2013 was $140,000 compared to $1.5 million for the same period in 2012. This decrease was primarily due to lower revenue recognized from the company's GPCR platform development funding agreement with Vulcan Inc. and its affiliate. While research continues under the company's GPCR program, no additional deferred revenue under the Vulcan agreement remains to be recognized after the first quarter of 2013.

For the quarter ended June 30, 2013, O
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Omeros to Present at the Wedbush 2013 Life Sciences Management Access Conference
2. Omeros Submits New Drug Application to U.S. FDA for OMS302
3. Omeros Reports Positive Results from OMS824 Positron Emission Tomography Clinical Trial
4. Omeros Files Clinical Trial Application for Lead Antibody in MASP-2 Program
5. Omeros Corporation Reports First Quarter 2013 Financial Results
6. Omeros Announces $16.2 Million Registered Direct Offering of Common Stock
7. Omeros Ophthalmology Product OMS302 Granted Eligibility for European Centralized Review
8. Omeros to Present Additional OMS302 Clinical Data at the Annual ASCRS and ASOA Symposium and Congress
9. Omeros Files Orphan Drug Application for Treatment of Atypical Hemolytic Uremic Syndrome with OMS721
10. Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
11. Omeros Announces Positive OMS721 Data in Model of Thrombotic Microangiopathy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Aug. 1, 2014 Research and ... "Global Medical Biosensors Market 2014-2018" report ... http://photos.prnewswire.com/prnh/20130307/600769 Medical biosensors are used ... physicochemical detectors. These biosensors monitor health status, disease ... non-invasive methods. They are cost-effective and user-friendly devices. ...
(Date:8/1/2014)... and PALO ALTO, Calif. , Aug. ... Inc. (CFRI) today announced a partnership to expand awareness ... community through the CFChef Shares program. CFChef Shares will ... part of AbbVie,s CFChef program – an online resource ... to maintain a healthy diet by submitting recipes to ...
(Date:8/1/2014)... DALLAS , August 1, 2014 ... Care Market by Type (Traditional Wound Closure, Anti infective), ... Active (Artificial Skin & Skin Substitutes), Pressure Relief ... by MarketsandMarkets, the global Wound Care Market is expected ... Billion in 2014, growing at a CAGR of ...
Breaking Medicine Technology:Global Medical Biosensors Market 2014-2018: Key Vendors are Abbott, Bayer, LifeScan and F. Hoffmann-La Roche 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 3Wound Care Market Worth $18.3 Billion by 2019 2Wound Care Market Worth $18.3 Billion by 2019 3
(Date:8/1/2014)... 2014 Lifeinsurancenomedicalexam.info has released a ... for clients who have high cholesterol levels. , ... and qualify for no medical exam life insurance. These ... background medical check-ups. , Since there are no medical ... will qualify in just a few minutes. However, this ...
(Date:8/1/2014)... According to Forrester Research, more than 90 percent ... search of information, and thanks to the launching of DCInsurers ... and resources on insurance specifically for the state of Colorado ... next step in the growth of our business,” Doug King, ... Commercial Insurance Resources office. “We recognize that the web is ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 Chilton ... portal that aims to empower patients and their ... their health care by providing easy, secure access ... gives patients instant, web-based access to their health ... radiology results, medications, allergies, demographic information, visit history, ...
(Date:8/1/2014)... Ohio (PRWEB) August 01, 2014 Home ... care for seniors, is honored to be recognized as a ... award is given to home care providers who rank in ... categories, based on monthly satisfaction interviews conducted by Home Care ... the leading home care businesses, the best of the best!” ...
(Date:8/1/2014)... August 01, 2014 Frontier Nursing University ... and Services Administration’s Advanced Education Nursing Traineeship (AENT) ... provide direct support to 280 students over the grant ... Program is to increase the number of advanced education ... nursing faculty to address the nurse faculty shortage that ...
Breaking Medicine News(10 mins):Health News:No Exam Life Insurance - Coverage for Clients Who Have High Cholesterol 2Health News:DCInsurers Agent Doug King Launches a New Website 2Health News:DCInsurers Agent Doug King Launches a New Website 3Health News:Chilton Medical Center Launches Online Patient Portal 2Health News:Cincinnati Senior Care Company Receives 2014 Best of Home Care® Employer of Choice Award 2Health News:Frontier Nursing University Receives $700,000 in Scholarships for Advanced Practice Nursing and Midwifery Students 2
... evaluating their risk for heart disease are missing a crucial ... University of Rochester Medical Center study published in the June ... that most doctors use to assess risk, known as Framingham ... of low income and/or less than a high school education ...
... , 2009 marks sixth consecutive year of support , ... Inc. announced today that the company has committed to raise ... Walk." The commitment represents the sixth consecutive year of ... , , "Safety-Kleen is firmly committed to its financial ...
... ... ... Sturchio, Chairman, Corporate Council on Africa, and Incoming President, Global Health Council ,Ms. Joan ... Department of State ,Dr. Kate Tulenko, Health Specialist, Coordinator of the Africa Health Workforce ...
... 16 The American Association of Oral ... (D-LA) on introducing S. 1235, the Senate companion ... and Surgery (CARES) Act . The bill would require ... Employee Retirement Income Security Act (ERISA) , ...
... Provide Personal Guide to Help Local Cancer Patients Better ... , , PHILADELPHIA, June 16 The ... at the Kimmel Cancer Center at Jefferson in Philadelphia, ... is the first site to launch in Pennsylvania as ...
... Inventive and Earth-friendly fibers are available to solve customers, needs ... ANSONVILLE, N.C., June 16 "Perpetual Innovation" should bring to ... products but also its process. That,s what Premiere Fibers does. ... www.premierefibers.com as well as a whole ...
Cached Medicine News:Health News:Income, education, important factors in heart disease risk 2Health News:Safety-Kleen Announces $100,000 Commitment to American Heart Association 'Start! Dallas Heart Walk' 2Health News:Building Healthcare Leadership in Africa: A Call to Action 2Health News:Oral and Maxillofacial Surgeons Applaud Senator Mary Landrieu (D-LA) For Introducing Legislation to Require Insurance Coverage for Children With Congenital Deformities 2Health News:Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 2Health News:Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 3Health News:Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 4Health News:Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program 5Health News:Premiere Fibers Unveils New Logo, Names for Innovative Brands 2
For the quantitative determination of Alanine Aminotransferase in serum. Optimized IFCC without P-5'-P, Linearity: 500 IU/L at 37 C. Liquid Working Reagent prepared with simple 1:9 dilution....
Intended for the quantitative determination of total protein in serum. Reaction: endpoint. Wavelength: 540 nm. Linearity: 12 g/dL (120 g/L). Ready to use liquid reagent....
Urea nitrogen (BUN) liquid reagent is used for the kinetic quantitative determination of Urea Nitrogen (BUN) in human serum used in routine examination and monitoring of therapy and relapses....
For the direct colorimetric determination of Urea Nitrogen (BUN) in human serum or plasma....
Medicine Products: